• CONTACT US
  • PARTICIPATE IN A TRIAL
  • Our Expertise
    • null

      Why Elixia?

      Our proven, consistent approach to clinical trial management delivers speed and efficiency, for every product and every phase.
      null

      Data & Analytics

      An analytics tool at the forefront of identifying unmet clinical needs and providing the industry with valuable post market data collection and analysis.
      ELIXIA CLINICAL EXCELLENCE CENTER
      null

      Phase I Unit

      Our well-equipped private research site offering comfortable participant accommodations
      null

      Rare Hepatorenal Disease

      Leveraging our in-depth expertise in the overlap of kidney, liver and heart disease.
      null

      Sleep Studies

      Evaluation, diagnosis and care for pediatric and adult patients in hotel-like surroundings.
  • Research Areas
    • null

      Cardio-Renal Network

      In depth clinical trial expertise in the overlap of cardiology and nephrology indications
      null

      Behavioral Health

      Leading access to diverse patient populations for behavioral health clinical trials
      null

      Infectious Disease

      Providing timely and robust clinical trial expertise to the new era of infectious disease research
  • About Elixia
    • null

      Who We Are

      Learn more about Elixia’s defining principles and core values
      null

      Contact Us

      Want to get in touch with our team? Simply fill out our contact form
      null

      Leadership

      Meet the team that fuels our agile approach to clinical trial conduct
      null

      Careers

      Explore opportunities with the team fueling medical discovery
  • Resources
  • Our Expertise
    • Why Elixia?
    • Data & Analytics
    • Phase I Unit
    • Rare Hepatorenal Disease
    • Sleep Studies
  • Research Areas
    • Cardio-Renal Network
    • Behavioral Health
    • Infectious Diseases
  • About Elixia
    • Who We Are
    • Leadership
    • Careers
    • Contact Us
  • Contact Us
  • Participate in a trial
logo
logo
  • Prev
  • Next

Do it right. Do it smart. Do it again.

Elixia is a clinical site organization that offers speed, agility and reproducibility – for every phase, every molecule, and every treatment.

Get Started
OUR EXPERTISE
    • Why Elixia?
    • Data & Analytics
    • Phase I Unit
    • Clinical Trials Management Portal
RESEARCH AREAS
    • Cardio-Renal Network
    • Behavioral Health
    • Infectious Disease
ABOUT ELIXIA
  • Who We Are
  • Leadership
  • Careers
  • Contact Us
Participate in a Trial
  • Privacy Policy
  • Terms of Use
  • Cookie Policy

© 2023 Elixia LLC. All Rights Reserved. ELIXIA and its distinctive “e” logo are registered trademarks of Elixia LLC.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}

Sam Searcy

Chief Commercial Officer

As Chief Commercial Officer, Sam Searcy is a cornerstone of Elixia’s strategic leadership, bringing an invaluable global network of leading pharmaceutical and contract research organizations to the table. His role is not just about connection, but about alignment – tactically coupling Elixia’s areas of therapeutic expertise with the appropriate organizations within the clinical trials landscape.

Elixia thrives on a disruptive and strategic operating model, a model that is considerably propelled by Sam’s relentless efforts. His unique ability to tap into key opinion leadership perspectives on the rapidly evolving clinical trials landscape equips Elixia with a strategic edge in efficiency and foresight. Sam’s role is instrumental in ensuring Elixia continues to offer first-in-class services and innovative opportunities to stakeholders in the drug development process.

Sam carries with him an ethos of operational excellence and innovation, a mindset born out of his extensive experience in the clinical trials industry. He has consistently demonstrated success in optimizing processes, making him an invaluable asset to Elixia as we forge strategic partnerships with top-tier pharmaceutical companies worldwide.

Sam Searcy’s dynamic leadership and strategic acumen are pivotal in Elixia’s mission to redefine the clinical trial landscape. His contributions embody Elixia’s collective ambition to continually push the boundaries of clinical research, and his drive and determination are integral to Elixia’s pursuit of excellence and our impact on patients across the globe.

 

Jennifer L. Yevoli

General Counsel

As General Counsel, Jennifer advises Elixia on a wide range of corporate, regulatory, contracting, and business issues and heads compliance and corporate integrity efforts across the organization.

Neal A. Patel

Chief Executive Officer

Neal Patel is a healthcare and biotechnology entrepreneur in both the Pharmaceutical and Biomedical marketplace. Neal founded his first clinical diagnostics company, at the age of 23. Armed with a passion for enhancing the accessibility to healthcare for disparate communities, Patel launched a private R&D Laboratory, responsible for engineering disruptive, cost-effective diagnostic tests focused on several cardiovascular indications. Over the next 3 years, Patel had developed one of the largest dedicated Cardiology networks for molecular diagnostics and clinical research on the east coast.

Maximizing the power of strategic foresight, Patel began developing a crossover network between Cardiology and Nephrology and in 2018 Elixia was born. Elixia’s Cardio-Renal Network became the largest dedicated footprint for clinical trials in the Southeast and is currently the fastest growing clinical trials footprint within the Cardio-Renal specialty in North America.

Under his leadership, Elixia’s total enterprise value has more than quadrupled, the number of employees tripled and the company has received numerous accolades for its work across several therapeutic focuses. Elixia’s mission is to redevelop the landscape in which clinical trials have been conducted over the last 50 years and deliver a new environment where Clinical Trial Rollout, Conduct, and Management can occur at breakneck pace with an unparalleled level of quality.

 

Jim F. Crissy

Chief Operating Officer

In his role of Chief Operating Officer for Elixia, Jim Crissy brings extensive industry and clinical trial management experience to the executive team. He provides strategic direction and operational oversight to a diverse and unique system of logistics that reflect the disruptive nature of Elixia’s forward approach to clinical trials.

Prior to joining Elixia in January 2019, Crissy served as COO of a company specialized in conducting Phase I-IV End Stage Renal Disease Trials. During this time, Crissy organized and managed a team that became well recognized as one of the top performing units on the East Coast in the Nephrology space. With over 18 years of experience operating in clinical trial management, Crissy has garnered a unique understanding of the evolution of clinical trial operating models – which accelerates Elixia’s ability to not only stay innovative and agile in the execution of novel workflows and trial management, but continue to challenge traditional trial management best practices.

Harry Alcorn

Chief Scientific Officer

Dr. Harry Alcorn is an integral part of the Elixia team, adding a rich tapestry of both scientific acumen and operational insight borne of over two decades of industry experience. Harry’s unique capability to seamlessly integrate operational strategy with a scientific approach is key to maintaining Elixia’s reputation as a forward-thinking, innovative, and reproducible trial management organization.

Serving as the head of operations in the Early Phase Clinical Trials Division of Elixia, Harry’s leadership is essential in driving our unique position as the only niche-focused clinical trials company conducting Phase I-IV trials. His profound expertise is instrumental in maintaining the company’s commitment to excellence, reliability, and innovation.

Harry joined Elixia in 2023, bringing with him a mission to create a comprehensive ecosystem of clinical trial services offered to the industry. Guided by this vision, he has been at the helm of the Phase I Division, overseeing a range of initiatives and ensuring the delivery of top-tier services.

Under Harry’s stewardship, Elixia continues to disrupt the clinical trial landscape, setting new standards and paving the way for future advancements. His unwavering dedication to improving patient outcomes, coupled with a deep commitment to scientific rigor, perfectly mirrors Elixia’s ethos.

Harry’s robust experience, passion for innovation, and strategic leadership are pivotal in Elixia’s pursuit to revolutionize the way clinical trials are conducted. His work is not just a testament to his individual expertise, but also a reflection of the collective drive of Elixia to make a profound impact on the lives of patients across the globe.